Development of Antibody-Oligonucleotide Complexes for Targeting Exosomal MicroRNA

MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to devel...

Full description

Saved in:
Bibliographic Details
Main Authors: Asako Yamayoshi (Author), Shota Oyama (Author), Yusuke Kishimoto (Author), Ryo Konishi (Author), Tsuyoshi Yamamoto (Author), Akio Kobori (Author), Hiroshi Harada (Author), Eishi Ashihara (Author), Hiroshi Sugiyama (Author), Akira Murakami (Author)
Format: Book
Published: MDPI AG, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody-anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs.
Item Description:10.3390/pharmaceutics12060545
1999-4923